SALARIUS PHARMACEUTICALS INC (SLRX)
US79400X4043 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -4.99M | -12.54M | -31.61M | -12.77M | -7.35M | |||
| Depreciation Amortization | 3.37K | 10.05K | 10.00K | 20.00K | 20.00K | |||
| Change In Working Capital | -615.31K | -968.33K | 2.37M | 2.03M | -3.04M | |||
| Interest Paid | 16.81K | 14.75K | 0.00 | 0.00 | 10.00K | |||
| Other non cash items | 307.53K | 654.84K | 11.64M | 510.00K | 60.00K | |||
| OPERATING CASH FLOW | -5.30M | -12.85M | -17.60M | -10.20M | -10.31M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Investing Activity | N/A | 0.00 | -1.50M | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | 0.00 | -1.50M | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -530.44K | -280.92K | 0.00 | -480.00K | -970.00K | |||
| Stock Issued/Repurchased | 1.53M | 6.92M | 1.99M | 28.77M | 18.67M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 996.55K | 6.64M | 1.99M | 28.30M | 17.69M | |||
| CHANGE IN CASH | -4.30M | -6.21M | -17.11M | 18.10M | 7.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.30M | -12.85M | -17.60M | -10.20M | -10.31M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | 0.00 | |||
| FREE CASH FLOW | -5.30M | -12.85M | -17.60M | -10.20M | -10.31M | |||
All data in USD